Alejandro Benjamin Balazs
NIH Rank #1584
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10210359Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$2.9M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#1,584
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Alejandro Benjamin Balazs as a PI. Multi-PI records show the full award amount for context.
- 5DP1DA060607-03DP1Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection$1.1Maward amount
- 1R56AI203781-01R56Improving the Innate Activity of Broadly Neutralizing Vectored Antibodies Against HIV$1Maward amount
- 5R01AI174276-03R01Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery$819.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Alejandro Benjamin Balazs as a PI.
FY2026 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3273
- 2024Entered Top 25% NationallyRanked #3273
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 10% NationallyRanked #1584